In a groundbreaking study published recently, researchers unveiled a meticulous validation of the positron emission tomography (PET) tracer ^18F-THK5351, a compound designed to illuminate the complex landscape of reactive astrogliosis within neurodegenerative disorders, notably Alzheimer’s disease. This innovative work breaks new ground in neuroimaging, emphasizing the tracer’s ability to selectively bind to monoamine oxidase-B (MAO-B), … Continue reading Validating 18F-THK5351 for Imaging Astrogliosis